- Home
- ELUT
ELUT
Elutia Inc.
as 05-20-2024 2:31pm EST
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
| Founded: | 2015 | Country: | MD |
| Employees: | N/A | City: | SILVER SPRING |
| Market Cap: | 79.9M | IPO Year: | 2020 |
| Target Price: | $4.00 | AVG Volume (30 days): | 54.0 |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.32 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.10 - $4.19 | Next Earning Date: | 05-09-2024 |
| Revenue: | $28,992,000 | Revenue Growth: | -7.86% |
| Revenue Growth (this year): | 9.03% | Revenue Growth (next year): | 47.45% |
Share on Social Networks:
Stock Insider Trading Activity of Elutia Inc. (ELUT)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Birchview Capital, LP | ELUT | Mar 23 '23 | Buy | $1.49 | 100,000 | $149,100.00 | 1,615,184 | SEC Form 4 | |
| Birchview Capital, LP | ELUT | Mar 23 '23 | Buy | $1.49 | 10,000 | $14,910.00 | 1,625,184 | SEC Form 4 | |
| Birchview Capital, LP | ELUT | Mar 23 '23 | Buy | $1.35 | 18,000 | $24,370.20 | 1,643,184 | SEC Form 4 | |
| Birchview Capital, LP | ELUT | Mar 23 '23 | Buy | $1.35 | 2,000 | $2,707.80 | 1,645,184 | SEC Form 4 | |
| Birchview Capital, LP | ELUT | Mar 23 '23 | Buy | $1.59 | 10,000 | $15,870.00 | 1,655,184 | SEC Form 4 |
Latest Elutia Inc. News
ELUT Breaking Stock News: Dive into ELUT Ticker-Specific Updates for Smart Investing
GlobeNewswire
7 days ago
Elutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024
GlobeNewswire
11 days ago
Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA Clearance
GlobeNewswire
18 days ago
Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
ACCESSWIRE
21 days ago
Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV
GlobeNewswire
a month ago
Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1
Simply Wall St.
2 months ago
Elutia Full Year 2023 Earnings: Misses Expectations
GlobeNewswire
2 months ago
Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024
GlobeNewswire
3 months ago